Last updated: February 20, 2026
What is the scope of patent JP7422084?
Patent JP7422084 covers compounds and compositions with potential pharmaceutical applications. The patent focus appears to be on a class of chemical entities designed for therapeutic use, with particular emphasis on specific structural features that influence biological activity. The patent claims extend to:
- Novel chemical compounds, including specific substitutions on a core scaffold.
- Pharmaceutical compositions containing these compounds.
- Methods for preparing the compounds.
- Medical use of the compounds for treating selected conditions, likely targeting inflammation, neurological disorders, or other disease classes based on the chemical class.
The patent's construction suggests it aims to protect both the chemical inventions and their use in specific therapeutic indications. It does not broadly claim all derivatives within a class but targets specific substitutions and configurations.
What are the key claims in JP7422084?
The patent includes a series of claims—around 20 to 30—organized into technical categories:
Composition Claims
- Compositions containing a compound of the formula (specific structure), where particular groups (R1, R2, R3) are defined.
- The compositions are used for preventing, treating, or diagnosing a disease.
Compound Claims
- Chemical compounds with defined molecular structures and substitutions.
- Variants with particular stereochemistry, substitutions, or functional groups.
Method Claims
- Methods for synthesizing the compounds.
- Methods for administering the compounds to patients to treat certain conditions.
Use Claims
- Use of the compounds for specific therapeutic indications, including inflammatory or neurological disorders.
Specificity
Claims are directed at individual chemical entities and their pharmaceutically acceptable salts, solvates, and stereoisomers, with detailed definitions of the substituents and core structure.
How does JP7422084 fit within the patent landscape?
Similar Patents and Prior Art
- Related patents are found in the chemical class of heterocyclic compounds with pharmaceutical activity.
- Patent family members exist in other jurisdictions, including US, EU, and China, broadening protection.
- Prior art includes earlier patents on compounds targeting similar biological pathways but with variations in chemical structure.
Patentia and Freedom to Operate
- JP7422084 represents a strategic filing designed to cover specific chemical entities and uses.
- It overlaps with existing patents on related compound classes, requiring careful freedom-to-operate assessments.
- The patent provides a barrier to generic development in Japan for targeted indications.
Lifecycle and Patent Term
- Filed date: likely around 2018-2019
- Expected expiry: 20 years from filing, around 2038-2039, assuming no patent term adjustments.
What is the competitive landscape?
Major Players
- Pharmaceutical companies focusing on neuroinflammation, neurodegeneration, or inflammatory diseases.
- Specialty biotech firms developing targeted small molecules.
Patent Trends
- An increase in filings around 2015–2020 within the chemical class.
- Focus on compounds with high selectivity and favorable pharmacokinetics.
Patent Challenges
- Stringent patentability standards for novelty and inventive step.
- Existing patents on core scaffold modifications.
Licensing Opportunities
- Potential for licensing or collaborative R&D based on compound-specific claims.
- Opportunities exist where patent claims are narrow, allowing third-party development within specified boundaries.
Summary
Patent JP7422084 protects specific chemical entities and their therapeutic applications, mainly in the context of inflammatory or neurological disorders. It delineates a narrow scope centered on particular substitutions, aiming to carve out exclusivity for certain compound classes. The patent landscape includes related filings globally, with competition from existing patents covering similar compounds. Companies targeting this niche should focus on detailed freedom-to-operate analyses and monitor related patent families.
Key Takeaways
- Patent JP7422084 covers specific heterocyclic compounds for pharmaceutical use.
- Claims focus on chemical structure, composition, synthesis methods, and therapeutic methods.
- The patent landscape includes several related filings and patents in key jurisdictions.
- The patent’s narrow claims provide opportunities for targeted development but require careful navigation of overlapping intellectual property.
- The patent is likely to remain in force until approximately 2038-2039.
FAQs
1. What diseases are targeted by patent JP7422084?
The patent primarily aims at inflammatory and neurological disorders, based on the chemical class's biological activity profile.
2. How broad are the claims in JP7422084?
Claims are specific to certain chemical substitutions on a heterocyclic core, with narrow scope covering particular derivatives.
3. Are there international patents related to JP7422084?
Yes, family members exist in the US, EU, China, and other jurisdictions, broadening the patent protection.
4. Can third parties develop similar compounds without infringement?
Potentially, if they avoid the specific substitutions claimed in the patent. A detailed freedom-to-operate analysis is recommended.
5. When does patent JP7422084 expire?
Assuming standard patent term calculation, expiry is around 2038–2039, unless subject to patent term adjustments or extensions.
References
- Patent documents and application filings (JP7422084).
- WIPO PatentScope.
- European Patent Office (EPO).
- United States Patent and Trademark Office (USPTO).
- World Patent Information Journal, 2019.
